Drawing for TEST, TRIGGER, TREAT

USPTO serial 79278716

TEST, TRIGGER, TREAT

Reviewed by CopyMark Law Group

Reg. 6458116Status 700Renewal
Filing date
Status date
Registration date
Aug 24, 2021
Examiner
CARR, PATRICK C
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with TEST, TRIGGER, TREAT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $548*

Plus Government fees of $650

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christina M. Licursi

Christina M. Licursi WOLF GREENFIELD & SACKS, P.C.600 ATLANTIC AVEBOSTON, MA 02210UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009scientific and measuring apparatus and instruments, namely, bioelectrical impedance measuring and recording apparatus and instruments to monitor for heart failure, heart disease, heart irregularities, organ failure or disease; mobile data apparatus and instruments, namely, mobile data receivers; mobile telephones; data processing equipment, namely, couplers; computers; downloadable computer programs and computer software for bioelectrical impedance measuring and recording, to operate bioimpedance analysis instruments and bioimpedance spectroscopy instruments, to record bodily functions, heart rate, biomass, body composition, cell composition and to record and process bioimpedance data; downloadable software applications for bioelectrical impedance measuring and recording, to operate bioimpedance analysis instruments and bioimpedance spectroscopy instruments, to record bodily functions, heart rate, biomass, body composition, cell composition and to record and process bioimpedance data; non-medical meters for measuring electrical current through humans; spectroscopes; non-medical devices for scientific use in measuring the composition of body fluids; telecommunications apparatus in the nature of wireless transmitters and receivers; communication devices, namely, cellphones and wireless communication devices for voice, data, and image transmission; monitoring apparatus, namely, alarm monitoring systems; apparatus for alarm signalling and receiving alerts, namely, alarm installations and alarms; emergency call telephone apparatus in the nature of a telephone terminal; non-medical sensors for measuring physical movements of a patient wearing or carrying the device, namely, sensor chips for scientific use; data processing equipment, namely, interface cards for data processing equipment in the form of printed circuits and computer hardware in the nature of central processing units; computers; downloadable computer programs and software for data measurement, data transformation, data storage, patient tracking, results interpretation, results analysis, and results display for application to bioimpedance readings generated by a bioimpedance analysis instrument or bioimpedance spectroscopy instrument; scientific and measuring apparatus and instruments for measuring and recording hydration, fluid density and retention in humans and animals; scientific and measuring apparatus and instruments for measuring and recording fluid levels in humans, animals, namely, extracellular fluid in human limbs; laboratory and scientific apparatus for use in testing, namely, research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; scientific apparatus for diagnostic testing of biological samples, other than for medical use, namely electronic analyzers for measuring, testing and analyzing blood and other bodily fluids; testing apparatus, not for medical purposes, namely, semiconductor testing apparatus; downloadable software for remote control and operation of scientific and measuring apparatus and instruments, namely, bioelectrical impedance measuring and recording apparatus and instruments; bio-sensors, namely, sensors that gather human biometric data and sensor chips, all for scientific use; test electrodes, other than for medical use; non-medical scientific measuring instruments for recording activity, size and performance of human or animal heart, lungs, bodily organs, cells, glands, in particular lymph glands, namely, to record fluid levels and retention in human or animal heart, lungs, bodily organs, cells, glands, in particular lymph glands; alarm signalling and receiving apparatus and alarm devices, other than for vehicles, namely, non-medical alarm sensors to monitor for heart failure, heart disease, heart irregularities, organ failure or disease and to monitor human vital signs and notify the wearer and third parties in relation to data relating to human vital signs in particular to fluid levels and retention in human or animal heart, lungs, bodily organs, cells, glands, in particular lymph glands; parts and accessories for use with all of the foregoingACTIVE—
010medical and veterinary apparatus and instruments, namely, bioelectrical impedance measuring and recording apparatus and instruments and accessories for estimating the composition of living matter; bioelectrical impedance analysis or bioimpedance spectroscopy devices for medical purposes; medical diagnostic testing apparatus, for testing for heart failure, heart disease, heart irregularities, organ failure or disease, and to monitor human vital signs and notify the wearer and third parties in relation to data relating to human vital signs in particular fluid levels and retention in human or animal heart, lungs, bodily organs, cells, glands in particular lymph glands; medical apparatus for the diagnosis and treatment of lymphoedema; medical spectroscopes; meters for body fluids for medical use; implantable devices for medical use in measuring the composition of body fluids; medical or veterinary meters for measuring electrical current passing through humans, animals; devices for medical and veterinary use, namely, instruments for use in clinical applications for determining body composition, segmental body composition, fluid level measurements, lymphedema assessment, detection and measurement, unilateral and bilateral, measurement, all in human or animal subjects; devices for medical and veterinary use, namely, instruments for use in clinical applications for determining hydration, measuring and recording fluid in humans, animals, namely, extracellular fluid in human limbs; consumable electrodes for medical use, electrodes for medical purposes, electrodes for picking up biological parameters for medical use, electrodes for use with medical apparatus, electrophysiology electrodes for medical use; medical electrodes; medical and veterinary apparatus and instruments for monitoring and recording activity, size and performance of human or animal heart, lungs, bodily organs, cells, glands, in particular lymph glands, in particular to record fluid levels and retention in human or animal heart, lungs, bodily organs, cells, glands in particular lymph glands; medical alarm and monitoring devices to monitor for heart failure, heart disease, heart irregularities, organ failure or disease, and to monitor to monitor human vital signs and notify the wearer and third parties in relation to data relating to human vital signs, in particular, to heart failure, heart disease, heart irregularities, organ failure or disease, and to monitor fluid levels and retention in human or animal heart, lungs, bodily organs, cells, glands, in particular lymph glands; electronic devices for assisting care giving for seniors or people needing assistance comprised of sensors for determining status of person and apparatus for sending electronic alerts to care givers, namely, sensors that gather human biometric data and sensor chips and also including wireless transmitters and receivers sold as a unit, all for medical use; medical products, namely, biofeedback sensors in the nature of electronic sensors to monitor people's health including monitoring for heart failure, heart disease, heart irregularities, organ failure or disease and monitoring human vital signs, namely, fluid levels and retention in human or animal heart, lungs, bodily organs, cells, glands in particular lymph glands and to notify the wearer and third parties in relation to data relating to those human vital signs; parts and accessories for use with all of the foregoingACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 24, 2026REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Feb 20, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 2, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 2, 2022FIMPFINAL DISPOSITION PROCESSED—
Nov 24, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 24, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 31, 2021OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jul 14, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jul 14, 2021OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jun 8, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 8, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 7, 2021GPNXNOTIFICATION PROCESSED BY IB—
May 19, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 19, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
May 19, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 4, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 4, 2021XAECEXAMINER'S AMENDMENT ENTERED—
May 4, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 4, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
May 4, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 21, 2020GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Oct 21, 2020GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 21, 2020CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 2, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 2, 2020ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Oct 2, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 2, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 28, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 28, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 28, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 17, 2020RFNTREFUSAL PROCESSED BY IB—
Mar 28, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 27, 2020RFRRREFUSAL PROCESSED BY MPU—
Mar 13, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 12, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 5, 2020DOCKASSIGNED TO EXAMINER—
Feb 25, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 19, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 13, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance